Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia.

Camilla de S Borges; Aline F Ferreira; Vitor H Almeida; Fausto G Gomes; Maria Gabriela Berzoti-Coelho; Maira da Costa Cacemiro; Natalia S Nunes; Lorena L Figueiredo-Pontes; Belinda P Simões; Fabíola A Castro; Robson Q Monteiro

doi:10.1016/j.exphem.2018.07.008

Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia.

Camilla de S Borges
, Aline F Ferreira
, Vitor H Almeida
, Fausto G Gomes
, Maria Gabriela Berzoti-Coelho
, Maira da Costa Cacemiro
, Natalia S Nunes
, Lorena L Figueiredo-Pontes
, Belinda P Simões
, Fabíola A Castro
, Robson Q Monteiro

Research output: Contribution to journal › Original Article › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	50-62
Journal	EXPERIMENTAL HEMATOLOGY
Volume	66
DOIs	https://doi.org/10.1016/j.exphem.2018.07.008
Publication status	Published - 2018

Keywords

ENDOTHELIAL GROWTH-FACTOR
CHRONIC MYELOGENOUS LEUKEMIA
KINASE INHIBITOR RESISTANCE
FACTOR SIGNALING PATHWAY
SMALL INTERFERING RNA
CANCER-CELLS
PROMOTES SURVIVAL
TUMOR PROGRESSION
PROSTATE-CANCER
UP-REGULATION

Access to Document

10.1016/j.exphem.2018.07.008

Cite this

Borges, C. D. S., Ferreira, A. F., Almeida, V. H., Gomes, F. G., Berzoti-Coelho, M. G., Cacemiro, M. D. C., Nunes, N. S., Figueiredo-Pontes, L. L., Simões, B. P., Castro, F. A., & Monteiro, R. Q. (2018). Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia. EXPERIMENTAL HEMATOLOGY , 66, 50-62. https://doi.org/10.1016/j.exphem.2018.07.008

Borges, Camilla de S ; Ferreira, Aline F ; Almeida, Vitor H et al. / Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia. In: EXPERIMENTAL HEMATOLOGY 2018 ; Vol. 66. pp. 50-62.

@article{7fd9f18e2bb746dcb1f150f2372024d9,

title = "Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia.",

keywords = "ENDOTHELIAL GROWTH-FACTOR, CHRONIC MYELOGENOUS LEUKEMIA, KINASE INHIBITOR RESISTANCE, FACTOR SIGNALING PATHWAY, SMALL INTERFERING RNA, CANCER-CELLS, PROMOTES SURVIVAL, TUMOR PROGRESSION, PROSTATE-CANCER, UP-REGULATION",

author = "Borges, \{Camilla de S\} and Ferreira, \{Aline F\} and Almeida, \{Vitor H\} and Gomes, \{Fausto G\} and Berzoti-Coelho, \{Maria Gabriela\} and Cacemiro, \{Maira da Costa\} and Nunes, \{Natalia S\} and Figueiredo-Pontes, \{Lorena L\} and Sim{\~o}es, \{Belinda P\} and Castro, \{Fab{\'i}ola A\} and Monteiro, \{Robson Q\}",

year = "2018",

doi = "10.1016/j.exphem.2018.07.008",

language = "English",

volume = "66",

pages = "50--62",

journal = "EXPERIMENTAL HEMATOLOGY ",

issn = "0301-472X",

}

Borges, CDS, Ferreira, AF, Almeida, VH, Gomes, FG, Berzoti-Coelho, MG, Cacemiro, MDC, Nunes, NS, Figueiredo-Pontes, LL, Simões, BP, Castro, FA & Monteiro, RQ 2018, 'Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia.', EXPERIMENTAL HEMATOLOGY , vol. 66, pp. 50-62. https://doi.org/10.1016/j.exphem.2018.07.008

Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia. / Borges, Camilla de S; Ferreira, Aline F; Almeida, Vitor H et al.
In: EXPERIMENTAL HEMATOLOGY , Vol. 66, 2018, p. 50-62.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia.

AU - Borges, Camilla de S

AU - Ferreira, Aline F

AU - Almeida, Vitor H

AU - Gomes, Fausto G

AU - Berzoti-Coelho, Maria Gabriela

AU - Cacemiro, Maira da Costa

AU - Nunes, Natalia S

AU - Figueiredo-Pontes, Lorena L

AU - Simões, Belinda P

AU - Castro, Fabíola A

AU - Monteiro, Robson Q

PY - 2018

Y1 - 2018

KW - ENDOTHELIAL GROWTH-FACTOR

KW - CHRONIC MYELOGENOUS LEUKEMIA

KW - KINASE INHIBITOR RESISTANCE

KW - FACTOR SIGNALING PATHWAY

KW - SMALL INTERFERING RNA

KW - CANCER-CELLS

KW - PROMOTES SURVIVAL

KW - TUMOR PROGRESSION

KW - PROSTATE-CANCER

KW - UP-REGULATION

U2 - 10.1016/j.exphem.2018.07.008

DO - 10.1016/j.exphem.2018.07.008

M3 - Original Article

C2 - 30076949

SN - 0301-472X

VL - 66

SP - 50

EP - 62

JO - EXPERIMENTAL HEMATOLOGY

JF - EXPERIMENTAL HEMATOLOGY

ER -

Borges CDS, Ferreira AF, Almeida VH, Gomes FG, Berzoti-Coelho MG, Cacemiro MDC et al. Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia. EXPERIMENTAL HEMATOLOGY . 2018;66:50-62. doi: 10.1016/j.exphem.2018.07.008